baber/WOPTO huggingface dataset:
Patent NZ-553970-A (NZ)
Title: Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators
Inventor: BARBANTI ELENA
IPC: A61P25/06
Filed: 2005-07-28
Abstract: Disclosed is the use of (R)-2-[4-(2-fluorobenzyloxy)benzylamino]propanamide as a single isomer of 2-[4-(2-fluorobenzyloxy)benzylamino]propanamide or (R)-2-[4-5 (2-chlorobenzyloxy)benzylamino]-N-methylpropanamide as a single isomer of 2-[4-(2-chlorobenzyloxy)benzylamino]-N-propanamide, or a pharmaceutically acceptable salts thereof for the manufacture of a medicament selectively active as sodium and/or calcium channel modulator suitable for preventing, alleviating and/or curing pathological diseases or conditions listed in the specification, wherein said medicament is substantially free from any MAO inhibitory effect or exhibits a significantly reduced MAO inhibitory effect at dosages that are therapeutically effective in preventing, alleviating and/or curing pathological diseases or conditions where the above said mechanism(s) play(s) a pathological role.
Patent NZ-554035-A (NZ)
Title: Corn event DAS-59122-7 and methods for detection thereof
Inventor: BING JAMES WAYNE
IPC: C12Q1/68
Filed: 2005-09-28
Abstract: Provided are isolated DNA molecules comprising specified nucleotide sequences pertaining to maize event DAS-59122-7, as well as primers and probes for the junction sequences between the inserted DNA and that plant native sequence. Further provided are methods of assaying for the maize event in plants, as well as plants and seeds containing the specified sequences.
Patent NZ-556047-A (NZ)
Title: Vehicle warning system
Inventor: FOYLE MATTHEW WILLIAM JAMES
Filed: 2007-06-21
Abstract: A vehicle (9) warning system (1) includes a warning indicator (2, 3) for emitting a warning signal detectable externally of the vehicle; a sensor (4) capable of detecting a speed, velocity and/or acceleration of the vehicle and a controller for receiving the sensor signal(s). The or each sensor is capable of providing a signal indicative of the speed, velocity and/or acceleration. The controller (6) is configured to determine the acceleration of the vehicle from the sensor signal and activate the warning indicator upon determining acceleration exceeding / deceeding a predetermined threshold limit. The predetermined threshold limit is a level of acceleration defined with respect to the rate of change of direction of the vehicle.
Patent NZ-568330-A (NZ)
Title: Stack ventable packs
Inventor: LEWITT JOHN
IPC: B65D5/00
Filed: 2008-05-14
Abstract: A rectangular based container assembled from a corrugated board main body blank 1 comprising a base 3, side wall panels 7, lid flaps 8 and end wall panels 5, and two end wall reinforcements 2 each comprising one or more laminations of corrugated paper board with a vertical flute run in the assembled container and at least one upstanding indexing projection 11. The body blank 1 has an indexing opening 4 for each projection 11. On assembly the body blank 1 provides side and end walls and lid flaps 8. The end wall panels 5 also provide flaps 6 that extend around the corner and are attached to the adjacent side wall. The container provides better ventilation to its contents.
Patent NZ-569433-A (NZ)
Title: GRG23 and GRG51 genes conferring herbicide resistance
Inventor: PETERS CHERYL L
IPC: C12Q1/48
Filed: 2006-12-01
Abstract: Disclosed is an isolated or recombinant nucleic acid molecule selected from the group consisting of: a) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO: 1, 3, or 5, or a complement thereof; b) a nucleic acid molecule comprising a nucleotide sequence having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO: 1, 3, or 5, or a complement thereof, wherein the polypeptide encoded by said nucleic acid molecule has glyphosate resistance activity; c) the herbicide resistance nucleotide sequence of the DNA insert of the plasmid deposited as Accession No. NRRL B-30888 or B-30949, or a complement thereof; d) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2, 4, or 6; and, e) a nucleic acid molecule comprising a nucleotide sequence encoding a polypeptide having at least 80% amino acid sequence identity to the amino acid sequence of SEQ ID NO: 2, 4, or 6, wherein said polypeptide has glyphosate resistance activity. Also disclosed is a method for conferring glyphosate resistance in a plant, said method comprising transforming said plant with a DNA construct, said construct comprising a promoter that drives expression in a plant cell operably linked with a nucleotide sequence at least 80% identical to the nucleotide sequence of SEQ ID NO: 1, 3, or 5, and regenerating a transformed plant.
Patent NZ-572630-A (NZ)
Title: System for communicating power system information through a radio frequency device
Inventor: SCHWEITZER EDMUND O
IPC: H04M3/00
Filed: 2007-05-18
Abstract: A system for communicating information between a detection device and a wireless device comprises a detection device (206, 207), a communication member (114a, 202) coupled to the detection device, a radio interface unit (400) in communication with the communication member and a wireless device (102, 104) in radio communication with the radio interface unit, such that the detection device communicates information between the wireless device via the radio interface unit. The detection device is adapted to monitor a condition related to a power system. The information includes status of coupling of the communication member and the detection device. The detection device is a power system device such as a faulted circuit indicator.
Patent NZ-576114-A (NZ)
Title: Spring biased mutually perpendicular double hinge for eye glasses
Inventor: IFERGAN NONU
IPC: G02C5/00
Filed: 2007-09-12
Abstract: A hinge assembly for eyeglasses having a pair of mutually perpendicular folding or pivot axes to permit movement about each axis for each respective temple arm and lens support assembly. A cam member is interposed between the temple and lens frame, with a flange directed towards the lens frame, a first pin extending between said lens support assembly and said flange to pivotally connect said lens support assembly and said flange to define a first axis of rotation, a first cam surface on the flange, a first cam follower engaged with said first cam surface, and a first spring biasing element acting between the first cam follower and the lens frame to oppose relative movement between the temple and the lens frame about the first pivot axis from a predetermined position; said cam member further having a tongue directed toward the temple, a second pin extending between the temple and the tongue to pivotally connect the temple and the tongue to define a second pivot axis orthogonal to said first pivot axis, a second cam surface on the tongue, a second cam follower engaged with the second cam surface, and a second spring biasing element acting between the second cam follower and the temple to oppose relative movement between said temple and said lens support structure about said second pivot axis from said predetermined position. The predetermined position is centrally located between the ranges of movement about each respective axis. The cam surfaces are shaped to return the temple to the central location. A central portion of the cam surfaces is at a minimum radius from the pivot axis and the radial spacing of the surface from the pivot axis progressively increases in radius to either side of said central portion. The cam followers are slidably mounted within the temples and lens frame. The bias springs are connected to an extension of the cam followers. The temples can be folded to a closed position and retained in that position by the cam followers acting upon the cam surfaces.
Patent NZ-581740-A (NZ)
Title: Gastroretentive system comprising an alginate body
Inventor: ASMUSSEN BODO
IPC: A61K9/24
Filed: 2008-05-27
Abstract: Disclosed is a gastroretentive system for the controlled, continuous release of active pharmaceutical ingredients in the stomach, comprising a) at least one release device for at least one active pharmaceutical ingredient, and b) at least one swelling body that is connected to the release device, wherein the swelling body is based on sodium alginate and, wherein calcium alginate or at least one pharmaceutically acceptable calcium salt selected from the group consisting of calcium acetate, calcium aspartate, calcium carbonate, calcium chloride, calcium citrate, calcium cyclamate, calcium folinate, calcium gluconate, calcium glutamate, calcium lactate, calcium lactate gluconate, calcium phosphate and calcium sulfate and/or at least one pharmaceutically acceptable zinc salt selected from the group consisting of zinc acetate, zinc aspartate, zinc bishydrogen aspartate, zinc chloride and zinc gluconate, and/or at least one pharmaceutically acceptable aluminium salt selected from the group consisting of aluminium hydroxide, algedrate (aluminium oxide) and aluminium phosphate added to the sodium alginate. Also disclosed is a method of producing said system.
Patent NZ-583330-A (NZ)
Title: Rodent trap with rotatable platform having an electrocution zone
Inventor: SYKES TYLER LENNY
IPC: A01M23/38
Filed: 2010-02-16
Abstract: Disclosed is an electrical rodent population control device (1). The device includes a rotatable passageway defining member (2), a power source, and an actuator (10). The passageway defining member includes a platform that can receive a rodent, the platform having an electrocution zone (5) where the rodent can be subjected to an electrical charge to kill the rodent. The passageway defining member includes an entrance opening (3) via which a live rodent can pass to move onto the platform and an exit opening (6) via which an electrocuted rodent can pass. The power source powers the electrocution zone. The actuator can rotate the passageway defining member between (a) a rodent supportable condition where a rodent can be vertically supported on the platform and (b) a rodent ejection condition where a rodent is able to slide off the platform and out of the passageway defining member via the exit opening.
Patent NZ-584968-A (NZ)
Title: Novel antiretroviral combination comprising ritonavir and atazanavir
Inventor: LULLA AMAR
IPC: B29C48/90
Filed: 2008-10-28
Abstract: Disclosed is a pharmaceutical composition comprising a solid unit dosage form comprising: (i) Ritonavir or a pharmaceutically acceptable salt thereof; (ii) Atazanavir or a pharmaceutically acceptable salt thereof. Which is a tablet formulation comprising said ritonavir in a first layer of the formulation and said atazanavir in a second layer of the formulation, and further comprising a water insoluble polymer and/or a water soluble polymer. Further disclosed is use of said composition in the manufacture of a medicament for treating HIV or AIDS. Also disclosed is a method for making said composition.
Patent NZ-587125-A (NZ)
Title: System to adjust the themal output of a heat engine driving a generator without changing the electrical output
Inventor: CHOKARDELL FLORIN SILVIU GABRIEL
IPC: F23N3/00
Filed: 2010-07-30
Abstract: Disclosed is a cogeneration system with variable air flow and fuel flow rates to change the output of the engine. The system comprises an external combustion Stirling cycle engine and a combustion chamber having a burner for supplying heat to the external combustion engine. A generator is driven by the external combustion engine for producing electricity and a heat exchanger recovers heat from the engine exhaust gases to produce a thermal air supply means capable of varying the flow rate of air to the engine. A fuel supply means varies the flow rate fuel to the engine and an electronic control system is arranged to increase the rate of air and fuel supply to the engine and to cause a flow or flows of additional air onto a heater head or heads of the engine to mix with combustion gases around the heater head or heads of the engine. The control system operates in a boost mode in response to a demand on the co-generation system for a boost level of thermal output which is higher than a normal level of thermal output such that thermal output of the cogeneration system is increased proportionately greater than any increase in electrical power output.
Patent NZ-592694-A (NZ)
Title: ATP-Binding Cassette (ABC) transporters as modulators of CFTR activity
Inventor: RUAH SARA HADIDA S
IPC: A61K31/404
Filed: 2008-11-12
Abstract: ABSTRACT - 592694 The disclosure relates to a compound represented by structural formula shown herein and pharmaceutically acceptable compositions thereof, which are useful as modulators of ATP-Binding Cassette ('ABC') transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), and are suitable for treating a condition, disease, or disorder selected from cystic fibrosis, hereditary emphysema, hereditary hemochromatosis, coagulation-fibrinolysis deficiencies, lipid processing deficiencies, lysosomal storage diseases, neurodegenerative diseases, polyglutamine neurological disorders, spongiform encephalopathies, chronic obstructive pulmonary disease (COPD), dry-eye disease, and Sjögren's disease.
Patent NZ-597803-A (NZ)
Title: Method for converting lignocellulosic materials into useful chemicals
Inventor: COURT GREGORY ROSS
IPC: C10G1/02
Filed: 2010-06-29
Abstract: 597803 Disclosed is a method of converting particulate lignocellulosic material to produce volatile organic compounds and char, comprising: forming a mixture of the particulate lignocellulosic material with a catalyst composition containing polar organic liquid and an acid, heating the mixture to a temperature sufficiently high and for a period sufficiently long as to convert a major portion of any remaining solid phase of the mixture to char whilst agitating the mixture and subjecting it to shearing and compression in the presence of steam, and separating the volatile organic compounds and the catalyst composition as a gaseous phase from the solid phase. The polar organic liquid is ideally an ionic liquid such as tetramethylene sulfone (sulfolane), and the acid is ideally a strong acid such as orthophosphoric acid
Patent NZ-600066-A (NZ)
Title: Plant growth regulation
Inventor: HAAS ULRICH JOHANNES
IPC: A01N43/828
Filed: 2010-11-24
Abstract: ABSTRACT - 600066 The disclosure relates to a method for regulating the growth of crop plants, comprising applying to the plants trinexapac-ethyl and acibenzolar-S-methyl in a weight ratio from 10:1 to 1:1. Also described is a method for regulating the growth of and/or enhancing crop plants, comprising applying to the plants a plant growth regulator and acibenzolar-S-methyl, wherein the plant growth regulator and acibenzolar-S-methyl are applied in a synergistically effective amount, and wherein the plant growth regulator may be selected from the group consisting of trinexapac-ethyl, prohexadione-calcium, paclobutrazol, uniconazole, flurprimidol, mefluidide, mepiquat-chloride, chlormequat-chloride, and a mixture thereof.
Patent NZ-600105-A (NZ)
Title: A bi-microporous/mesoporous composite molecular sieve and preparation process thereof
Inventor: GUO SHUZHI
IPC: B01J32/00
Filed: 2010-09-07
Abstract: 600105 DOUBLE MICRO-MESOPOROUS COMPOSITE MOLECULAR SIEVE AND PREPARATION METHOD THEREOF A double micro-mesoporous composite molecular sieve and preparation method thereof are provided. Said molecular sieve is prepared by combining Y and 0 microporous zeolites with MCM-41 molecular sieve. The pore wall of hexagonal mesoporous phase is wrapped with double microporous phase, which presents many hollow shell structure of spherical or hemispherical shape. A net structure is formed by the cross-linking of said hollow shell structure with each other, the silica-alumina ratio of microporous phase and the content of microporous phase can be adjusted. The preparation method comprises: a mixed solution of hexadecyl trimethyl ammonium bromide and polyoxyethylene alkylphenol ether is used as template agent. The pretreated double microporous phase and the silica source and/or alumina source for synthesizing mesoporous phase are added into the system respectively. The Y-0/MCM-41 double microporous and mesoporous composite molecular sieve which has adjustable silica-alumina ratio of microporous phase and content of microporous phase is obtained by hydrothermal crystallizing process.
Patent NZ-602652-A (NZ)
Title: Dairy-based foods having high levels of lactose with low levels of lactose crystallization
Inventor: SMITH GARY FRANCIS
IPC: A23C1/12
Filed: 2012-09-26
Abstract: NZ 602652 Disclosed is a dairy-based comestible having high levels of lactose in moisture and a smooth texture. The disclosed dairy-based comestible comprises: a dairy protein component providing dairy protein and lactose to the dairy-based comestible; about 14 to about 22% lactose; about 10 to about 65% moisture; a lactose-in-moisture phase of about 30 to about 50% calculated as the weight percent lactose divided by the sum of the weight percent lactose plus the weight percent moisture; and a maximum temperature exposure of the dairy protein component between about 130°F and 155°F effective such that lactose crystal sizes are an average of about 100 microns or below within the moisture phase to provide a smooth texture to the dairy-based comestible.
Patent NZ-603261-A (NZ)
Title: Anticancer steroidal lactones unsaturated in position 7 (8)
Inventor: REYES BENITEZ JOSE FERNANDO
IPC: C07J19/00
Filed: 2011-04-26
Abstract: The disclosure relates to a compound of general formula (I), wherein R1-R17 and the ------ line are as defined in the specification. Specific examples of these steroidal lactones were isolated from the organism Mycale (Aegogropila) crassissima and are given the names Aegomycin A - H. The disclosure also relates to pharmaceutical compositions comprising these compounds and their use in the treatment of cancer.
Patent NZ-607733-A (NZ)
Title: Intelligent core engine
Inventor: DODDERI RUCHACLI
IPC: G01D4/00
Filed: 2011-07-22
Abstract: A central management authority for a system, such as a power utility system, is disclosed. The central management authority communicates with a plurality of meter data management systems and with a plurality of headend systems, the meter data management systems generating commands and the headend systems communicating with one or more meters (such as one or more smart meters). The central management authority includes a gateway layer (60) and a core layer (55). The gateway layer includes a plurality of input connector routines to communicate with each of the plurality of source systems (65, 70) and a plurality of output connector routines to communicate with each of the plurality of target systems (75, 80). The core layer includes a plurality of core adapters, with the core adapters performing a one-to-one translation of communications from the plurality of meter data management systems generating commands to the plurality of the head end systems. The source and target systems may each be either a meter data management system or head end system depending on the type of communication occurring. Either may send data through the gateway and core to the other.
Patent NZ-610806-A (NZ)
Title: Laundry treating appliance and method of control
Inventor: MERKLE SCOTT A
IPC: D06F33/02
Filed: 2013-05-20
Abstract: 610806 – Mitigating suds lock by rinsing during deceleration of washing basket. To reduce suds build-up and thus mitigate possible suds lock during the spin cycle, the wash liquid is drained from the tub 102, the wash basket is spun up to a first rotation speed 104 then allowed to decelerate or is braked 106, and, during the deceleration phase, rinse liquid is sprayed into the tub 108. This cycle may be repeated 110 with successive increases in the speed to which the basket is accelerated in order to reduce suds before the basket is spun up to extract water from the clothes in the basket.
Patent NZ-611740-A (NZ)
Title: Hydrophilic end seal
Inventor: KIEST JR LARRY W
IPC: F16L55/179
Filed: 2011-12-06
Abstract: 611740 A kit, apparatus, and method for sealing a junction between a manhole and a pipe within a sewer system are provided. In a first embodiment, the end of a pipe adjacent a manhole is sealed by the use of a pipe liner and a tubular sleeve made of a hydrophilic material. The tubular sleeve is held in place by a mechanical fastener and a pipe liner is installed or otherwise placed through the tubular sleeve and against the wall of the pipe. In a second embodiment, a majority of the area surrounding a junction of a pipe and a manhole is sealed by the use of a tubular sleeve made of a hydrophilic material including a flange portion, a mechanical fastener, a pipe liner, and a manhole liner.
Patent NZ-614125-A (NZ)
Title: Cea antibodies
Inventor: MOESSNER EKKEHARD
IPC: C07K16/30
Filed: 2012-02-29
Abstract: Disclosed is an isolated antibody which binds to membrane bound carcinoembryonic antigen (CEA), that comprises the CDRs/heavy and light chains of the sequences as defined in the specification. Also disclosed is the use of the antibodies for the manufacture of a medicament for treating a subject having a cancer that abnormally expresses CEA.
Patent NZ-615215-A (NZ)
Title: Retaining device
Inventor: CANEPARI ENEA
IPC: E01F7/04
Filed: 2012-02-09
Abstract: 615215 A retaining device has a retaining barrier, wherein the retaining barrier comprises a support frame including at least three arms (51, 52, 53, 54). The support frame is adapted to assume a non-operating closed configuration and an operating radial configuration. In operating radial configuration, each arm (51, 52, 53, 54) is oriented along a respective radial direction); in non- operating closed configuration, at least a first arm (51, 53) is oriented along the same radial direction of the operating radial configuration and the remaining second arms ( 52, 54) are oriented along a direction substantially parallel to said radial direction of said at least one first arm (51, 53).
Patent NZ-616028-A (NZ)
Title: Crystalline and non-crystalline forms of tofacitinib, and a pharmaceutical composition comprising tofacitinib and a penetration enhancer
Inventor: MURPHY BRENDAN J
IPC: C07D487/04
Filed: 2012-03-29
Abstract: The disclosure relates to crystalline and non-crystalline forms of 3-((3R, 4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxopropionitrile (tofacitinib). The disclosure also relates to pharmaceutical compositions comprising tofacitinib and a penetration enhancer. The penetration enhancer may be oleyl alcohol, linoleyl alcohol, y-linolenyl alcohol, linolenyl alcohol, decyl alcohol, lauryl alcohol, myristyl alcohol, cetyl alcohol, stearyl alcohol, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid and arachidic acid, palmitoleic acid, oleic acid, cis-vaccenic acid, linoleic acid, y-linolenic acid, linolenic acid or arachidonic acid. The disclosure also relates to the use of the pharmaceutical compositions in the treatment of disease, such as psoriasis.